Expertise in
8
conditions

Tomoya Yokota

Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, 
Shimonagakubo, JP 
Expertise in
8
conditions
Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, 
Shimonagakubo, JP 

Overview

Tomoya Yokota practices practicing medicine in Shimonagakubo, Japan.

Mr. Yokota is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Esophageal Cancer, Stomach Cancer, Gastrostomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 124 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, Shimonagakubo, 4118777, Japan
Other Locations
Department Of Head And Neck Medical Oncology, Sunto Gun, Shizuoka, Japan
Kobe, Japan
Inage, 2638522, Japan
Kashiwa, Japan
Kawahara, 6068507, Japan
Nagoya, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3
A Phase 1 Study of an ERK1/2 Inhibitor (LY3214996) Administered Alone or in Combination With Other Agents in Advanced Cancer
A Phase 1 Study of an ERK1/2 Inhibitor (LY3214996) Administered Alone or in Combination With Other Agents in Advanced Cancer
Enrollment Status: Completed
Publish Date: November 22, 2022
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

124 Total Publications

Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Journal: International journal of clinical oncology
Published: July 09, 2026

Frequently Asked Questions about Tomoya Yokota

Is Tomoya Yokota a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Tomoya Yokota is classified as an Distinguished expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tomoya Yokota participate in research or clinical trials?

Yes. Tomoya Yokota has published 124 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Tomoya Yokota's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yokota's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile